Free Trial
CVE:SCYB

Scythian Biosciences (SCYB) Stock Price, News & Analysis

C$3.49 -0.22 (-5.93%)
As of 07/25/2018

About Scythian Biosciences Stock (CVE:SCYB)

Key Stats

Today's Range
C$3.46
C$3.77
50-Day Range
C$3.49
C$3.49
52-Week Range
C$1.01
C$8.61
Volume
703,164 shs
Average Volume
231,491 shs
Market Capitalization
C$102.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SCYB Stock News Headlines

Scryb Inc. (SCYRF)
Schwab High Yield Bond ETF (SCYB)
Trump’s Secret Social Security Plan?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
Scryb Inc SCYB
Scryb Inc. (SCYB.CN)
Ventrus Biosciences (VTUS) Stock Surges Today
Canadian Jobs to be Presented Next Friday
See More Headlines

SCYB Stock Analysis - Frequently Asked Questions

Scythian Biosciences' stock was trading at C$3.49 on January 1st, 2025. Since then, SCYB shares have increased by 0.0% and is now trading at C$3.49.
View the best growth stocks for 2025 here
.

Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scythian Biosciences investors own include DraftKings (DKNG), Lithium South Development Co. (NGZ.V) (NGZ), Organigram (OGI), Scythian Biosciences (SCCYF), SOL Global Investments (SOLCF), CanniMed Therapeutics (CMED) and Compugen (CGEN).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SCYB
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$102.38 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:SCYB) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners